TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Oxford Instruments ( (GB:OXIG) ) just unveiled an announcement.
Oxford Instruments plc has announced that as of September 30, 2025, its issued share capital with voting rights consists of 56,936,273 ordinary shares. This figure is significant for shareholders as it serves as the denominator for calculating their interests or changes in interests in compliance with the UK Financial Conduct Authority’s Disclosure Guidance and Transparency Rules. This update ensures transparency and aids stakeholders in maintaining compliance with regulatory requirements.
The most recent analyst rating on (GB:OXIG) stock is a Hold with a £2017.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.
Spark’s Take on GB:OXIG Stock
According to Spark, TipRanks’ AI Analyst, GB:OXIG is a Neutral.
Oxford Instruments’ strong financial performance is the primary driver of its score, supported by consistent revenue growth and solid profitability margins. However, high valuation and neutral technical indicators suggest caution. Addressing liquidity and profitability challenges will be crucial for future growth.
To see Spark’s full report on GB:OXIG stock, click here.
More about Oxford Instruments
Oxford Instruments is a company operating in the scientific and industrial instrumentation industry, focusing on the development and provision of high-technology tools and systems that serve research and industrial applications. The company is known for its advanced products that cater to sectors such as materials science, nanotechnology, and quantum technology.
Average Trading Volume: 120,655
Technical Sentiment Signal: Hold
Current Market Cap: £1.06B
Learn more about OXIG stock on TipRanks’ Stock Analysis page.